Datasheet
- Strength per vial
- CJC-1295 without DAC 5 mg + Ipamorelin 5 mg (10 mg total)
- SKU
- CP10
- CAS number
- CJC-1295 (no DAC): 863288-34-0 · Ipamorelin: 170851-70-4
- Formula
- CJC-1295 (no DAC): C₁₅₂H₂₅₂N₄₄O₄₂ · Ipamorelin: C₃₈H₄₉N₉O₅
- Molecular weight
- CJC-1295 (no DAC): 3367.9 g/mol · Ipamorelin: 711.9 g/mol
- Form
- Lyophilized powder
- Storage
- −20 °C long-term. Keep sealed, dry and away from light.
Growth axis
CJC-1295 (no DAC) + Ipamorelin
A blend of CJC-1295 without DAC and ipamorelin, two peptides that act on different receptors, supplied together in one vial.
$40.00 per vial
In stockIn stock — ready to ship.
Total for 1 vial: $40.00 before shipping and tax.
Save more on larger orders
- 3% off with 3+ vials
- 5% off with 6+ vials
- 8% off with 10+ vials
- Ships free when everything is in stock
- Pay with Bitcoin and save 20%
- Ships together, date shown before you pay
- Secure card payment through Stripe
- Each vial bubble-wrapped and padded
For laboratory research use only. Not for human or veterinary use.
Datasheet
- Strength per vial
- CJC-1295 without DAC 5 mg + Ipamorelin 5 mg (10 mg total)
- SKU
- CP10
- CAS number
- CJC-1295 (no DAC): 863288-34-0 · Ipamorelin: 170851-70-4
- Formula
- CJC-1295 (no DAC): C₁₅₂H₂₅₂N₄₄O₄₂ · Ipamorelin: C₃₈H₄₉N₉O₅
- Molecular weight
- CJC-1295 (no DAC): 3367.9 g/mol · Ipamorelin: 711.9 g/mol
- Form
- Lyophilized powder
- Storage
- −20 °C long-term. Keep sealed, dry and away from light.
This blend combines CJC-1295 without DAC (modified GRF 1-29), a stabilised analogue of growth-hormone-releasing hormone, with ipamorelin, a pentapeptide agonist of the growth hormone secretagogue receptor. The two act on different receptors: GHRH and ghrelin. Each strength lists 5 mg of each peptide per vial.
- CAS number
- CJC-1295 (no DAC): 863288-34-0 · Ipamorelin: 170851-70-4
- Molecular formula
- CJC-1295 (no DAC): C₁₅₂H₂₅₂N₄₄O₄₂ · Ipamorelin: C₃₈H₄₉N₉O₅
- Molecular weight
- CJC-1295 (no DAC): 3367.9 g/mol · Ipamorelin: 711.9 g/mol
- Form
- Lyophilized powder
- Storage
- −20 °C long-term. Keep sealed, dry and away from light.
- Sequence
- CJC-1295 (no DAC): Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH₂ · Ipamorelin: Aib-His-D-2Nal-D-Phe-Lys-NH₂
- CJC-1295 without DAC is modified GRF 1-29, with amino-acid substitutions that make it more stable than native GRF 1-29
- The cited studies describe CJC-1295 with DAC, the longer-acting albumin-binding form, which is a separate compound
- Ipamorelin is a pentapeptide agonist of the growth hormone secretagogue receptor
- 01Human growth hormone-releasing factor (hGRF)1-29-albumin bioconjugates activate the GRF receptor on the anterior pituitary in rats: identification of CJC-1295 as a long-lasting GRF analog. Endocrinology (2005)
- 02Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog. J Clin Endocrinol Metab (2006)
- 03Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol (1998)